Authors:
Villacres, MC
Lacey, SF
La Rosa, C
Krishnan, R
Auge, C
Longmate, J
Zaia, JA
Leedom, JM
Diamond, DJ
Citation: Mc. Villacres et al., Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8(+) T cell subsets as a strong adaptive immune response to cytomegalovirus, J INFEC DIS, 184(3), 2001, pp. 256-267
Authors:
Legaigneur, P
Breton, C
El Battari, A
Guillemot, JC
Auge, C
Malissard, M
Berger, EG
Ronin, C
Citation: P. Legaigneur et al., Exploring the acceptor substrate recognition of the human beta-galactosidealpha 2,6-sialyltransferase, J BIOL CHEM, 276(24), 2001, pp. 21608-21617
Authors:
Auge, C
Malleron, A
Tahrat, H
Marc, A
Goergen, JL
Cerutti, M
Steelant, WFA
Delannoy, P
Lubineau, A
Citation: C. Auge et al., Outstanding stability of immobilized recombinant alpha(1 -> 3/4)-fucosyltransferases exploited in the synthesis of Lewis a and Lewis x trisaccharides, CHEM COMMUN, (20), 2000, pp. 2017-2018
Authors:
Harduin-Lepers, A
Stokes, DC
Steelant, WFA
Samyn-Petit, B
Krzewinski-Recchi, MA
Vallejo-Ruiz, V
Zanetta, JP
Auge, C
Delannoy, P
Citation: A. Harduin-lepers et al., Cloning, expression and gene organization of a human Neu4Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAc IV, BIOCHEM J, 352, 2000, pp. 37-47
Authors:
BenMohamed, L
Krishnan, R
Longmate, J
Auge, C
Low, L
Primus, J
Diamond, DJ
Citation: L. Benmohamed et al., Induction of CTL response by a minimal epitope vaccine in HLA A0201/DR1 transgenic mice: Dependence on HLA class II restricted T-H response, HUMAN IMMUN, 61(8), 2000, pp. 764-779
Authors:
Pykari, M
Toivonen, S
Natunen, J
Niemela, R
Salminen, H
Aitio, O
Ekstrom, M
Parmanne, P
Valimaki, M
Alais, J
Auge, C
Lowe, JB
Renkonen, O
Renkonen, R
Citation: M. Pykari et al., The acceptor and site specificity of alpha 3-fucosyltransferase V - High reactivity of the proximal and low of the distal, Gal beta 1-4GlcNAc unit ini-type polylactosamines, J BIOL CHEM, 275(51), 2000, pp. 40057-40063